Reagents For The Lab

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.

Active Agents, Antibodies WB, Antibody, Apoptosis Test, Assay Kits, Assays EIA, Elisa Assay, Elisa Kits, Enzymes, Equipments, Exosomes, FITC, Gels, Gene Data, Main, Polyclonal, Questions, Reagents For The Lab, Recombinant Proteins, Ria Kits, RNA, Southern Blot, Staining Kits, Support, T Cells, Tech File, Test Kits, Vial / By

Sclerostin, bone formation antagonist is in the spotlight as a potential biomarker for diseases presenting with associated bone disorders such as chronic kidney disease (CDK-MBD). Accurate measurement of sclerostin is therefore important. Several immunoassays are available to measure sclerostin in serum and plasma. We compared the performance of three commercial ELISA kits. We measured sclerostin …

How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits. Read More »

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease.

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease.

Active Agents, Antibodies, Antibodies WB, Antibody, Apoptosis Test, Assay Kits, Assays EIA, Exosomes, FITC, Gels, Gene Data, GFP, Histology, IHC, Immunoglobulin, Main, Polyclonal, Questions, Reagents, Reagents For The Lab, Recombinant Proteins, Ria Kits, RNA, Southern Blot, Support, T Cells, Tech File, Test Kits, Vial / By

Lyme disease (LD), caused by infection with Borrelia burgdorferi, is the most common tick-borne infection in many regions of Eurasia. Antibody detection is the most frequently used laboratory test, favoring a two-step serodiagnostic algorithm; immunoenzymatic detection of antibodies to C6 has been shown to perform similarly to a standard two-step workflow. The aim of this study …

Multicenter Evaluation of the C6 Lyme ELISA Kit for the Diagnosis of Lyme Disease. Read More »

Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID-19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits

This study aims to study the immune response and evaluate the performances of four new IgM and five IgG enzyme-linked immunosorbent assay (ELISA) kits for detecting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies against different antigens in symptomatic and asymptomatic coronavirus disease 2019 (COVID-19) patients.

Antibodies, Antibodies WB, Apoptosis Test, Assay Kits, Biology Cells, Blotting, cDNA, Cell Markers, Cellular Research, Cellular Staining, Clia Kits, Culture Cells, Devices, DNA, DNA Templates, DNA Testing, Elisa Kits, Enzymes, Equipments, Exosomes, Gels, Histology, Immunoglobulin, Isotypes, Main, Markers, Medium & Serums, Mouse Research, NATtrol, Panel, Particles, PCR, Pcr Kits, Peptide, Peptides, Reagents, Reagents For The Lab, Recombinant Proteins, Ria Kits, RNA, Southern Blot, Staining Kits, Support, T Cells, Test Kits, Vial / By

A total of 291 samples collected from symptomatic and asymptomatic RT-PCR-confirmed patients were used to evaluate the ELISA kits’ performance (EDI, AnshLabs, DiaPro, NovaLisa, and Lionex). The sensitivity was measured at three different time-intervals post symptoms onset or positive SARS-CoV-2 RT-PCR test (≤14, 14-30, >30 days). The specificity was investigated using 119 pre-pandemic serum samples. …

This study aims to study the immune response and evaluate the performances of four new IgM and five IgG enzyme-linked immunosorbent assay (ELISA) kits for detecting anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies against different antigens in symptomatic and asymptomatic coronavirus disease 2019 (COVID-19) patients. Read More »